[THE SECONDARY EFFECTS OF NEUROLEPTICS].
D014150:Antipsychotic Agents; D002746:Chlorpromazine; D005476:Fluphenazine; D006801:Humans; D007022:Hypotension; D007099:Imipramine; D008728:Methotrimeprazine; D010640:Phenothiazines; D010879:Piperazines; D007319:Sleep Initiation and Maintenance Disorders; D013881:Thioridazine; D014116:Toxicology; D014149:Tranquilizing Agents; D014282:Trihexyphenidyl
D014150:Antipsychotic Agents; D010640:Phenothiazines; D010879:Piperazines; D014149:Tranquilizing Agents; D014282:Trihexyphenidyl; D008728:Methotrimeprazine; C031637:phenothiazine; D013881:Thioridazine; D007099:Imipramine; D005476:Fluphenazine; D002746:Chlorpromazine
CHLORPROMAZINE; FLUPHENAZINE; HYPOTENSION; IMIPRAMINE; INSOMNIA; METHOTRIMEPRAZINE; PHENOTHIAZINES; PIPERAZINES; THIORIDAZINE; TOXICOLOGIC REPORT; TRANQUILIZING AGENTS; TRIHEXYPHENIDYL
LES EFFETS SECONDAIRES DES NEUROLEPTIQUES.